✦ LIBER ✦

Disease Flare After EGFR Tyrosine Kinase Inhibitor Cessation Predicts Poor Survival in Patients with Non-small Cell Lung Cancer

✍ Scribed by Hua-Jun Chen, Hong-Hong Yan, Jin-Ji Yang, Zhi-Hong Chen…

Book ID: 120957595
Publisher: Springer Netherlands
Year: 2013
Tongue: English
Weight: 214 KB
Volume: 19
Category: Article
ISSN: 1219-4956
DOI: 10.1007/s12253-013-9651-z

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Volumetric tumor growth in advanced non-

Volumetric tumor growth in advanced non-small cell lung cancer patients with EGFR mutations during EGFR-tyrosine kinase inhibitor therapy

✍ Nishino, Mizuki; Dahlberg, Suzanne E.; Cardarella, Stephanie; Jackman, David M.; 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 311 KB

Pretreatment Epidermal Growth Factor Rec

Pretreatment Epidermal Growth Factor Receptor (EGFR) T790M Mutation Predicts Shorter EGFR Tyrosine Kinase Inhibitor Response Duration in Patients With Non-Small-Cell Lung Cancer

✍ Su, K.-Y.; Chen, H.-Y.; Li, K.-C.; Kuo, M.-L.; Yang, J. C.-H.; Chan, W.-K.; Ho, 📂 Article 📅 2012 🏛 American Society of Clinical Oncology 🌐 English ⚖ 676 KB

Readministration of EGFR Tyrosine Kinase

Readministration of EGFR Tyrosine Kinase Inhibitor in Non-small Cell Lung Cancer Patients after Initial Failure, What Affects its Efficacy?

✍ Zhao, Ze-Rui; li, Wei; Long, Hao 📂 Article 📅 2014 🏛 Springer Science and Business Media LLC 🌐 English ⚖ 296 KB

Characterization of skin pathology in no

Characterization of skin pathology in non–small cell lung cancer patients treated with the EGFR tyrosine kinase inhibitor erlotinib

📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 45 KB

Immediate versus delayed treatment with

Immediate versus delayed treatment with EGFR tyrosine kinase inhibitors after first-line therapy in advanced non-small-cell lung cancer

✍ Zhi-jie Wang; Tong-tong An; Tony Mok; Lu Yang; Hua Bai; Jun Zhao; Jian-chun Duan 📂 Article 📅 2011 🏛 Chinese Anti-Cancer Association 🌐 English ⚖ 359 KB

Efficacy of EGFR Tyrosine Kinase Inhibit

Efficacy of EGFR Tyrosine Kinase Inhibitors in Patients With EGFR-Mutated Non–Small-Cell Lung Cancer: A Meta-Analysis of 13 Randomized Trials

✍ Fausto Petrelli; Karen Borgonovo; Mary Cabiddu; Sandro Barni 📂 Article 📅 2012 🏛 CIG Media Group, LP. 🌐 English ⚖ 473 KB